# Repurposing Tilmanocept for Cardiac Sarcoidosis

> **NCT07159074** · PHASE2 · RECRUITING · sponsor: **Duke University** · enrollment: 15 (estimated)

## Conditions studied

- Cardiac Sarcoidosis

## Interventions

- **DRUG:** Tc 99m tilmanocept
- **DRUG:** Tc 99m tilmanocept

## Key facts

- **NCT ID:** NCT07159074
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07159074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07159074, "Repurposing Tilmanocept for Cardiac Sarcoidosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07159074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*